chr1-159205564-G-A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002036.4(ACKR1):c.125G>A(p.Gly42Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 1,613,990 control chromosomes in the GnomAD database, including 269,798 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002036.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.642 AC: 97626AN: 152086Hom.: 34532 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.512 AC: 128658AN: 251268 AF XY: 0.506 show subpopulations
GnomAD4 exome AF: 0.555 AC: 811380AN: 1461786Hom.: 235211 Cov.: 66 AF XY: 0.548 AC XY: 398869AN XY: 727200 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.642 AC: 97720AN: 152204Hom.: 34587 Cov.: 33 AF XY: 0.629 AC XY: 46835AN XY: 74408 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
p.Gly42Asp in exon 2 of DARC: This variant is not expected to have clinical sign ificance because it has been identified in 92.68% (9644/10406) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs12075). -
not provided Benign:1
- -
ACKR1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
DUFFY BLOOD GROUP SYSTEM, FYA/FYB POLYMORPHISM Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at